16-70938692-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001270974.2(HYDIN):​c.6917A>G​(p.Glu2306Gly) variant causes a missense change. The variant allele was found at a frequency of 0.693 in 1,612,490 control chromosomes in the GnomAD database, including 402,741 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 28289 hom., cov: 32)
Exomes 𝑓: 0.71 ( 374452 hom. )

Consequence

HYDIN
NM_001270974.2 missense

Scores

2
6
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 6.29

Publications

25 publications found
Variant links:
Genes affected
HYDIN (HGNC:19368): (HYDIN axonemal central pair apparatus protein) This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]
HYDIN Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, ClinGen, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.3903714E-6).
BP6
Variant 16-70938692-T-C is Benign according to our data. Variant chr16-70938692-T-C is described in ClinVar as Benign. ClinVar VariationId is 402955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.745 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HYDINNM_001270974.2 linkc.6917A>G p.Glu2306Gly missense_variant Exon 44 of 86 ENST00000393567.7 NP_001257903.1 Q4G0P3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HYDINENST00000393567.7 linkc.6917A>G p.Glu2306Gly missense_variant Exon 44 of 86 5 NM_001270974.2 ENSP00000377197.2 Q4G0P3-1
HYDINENST00000309900.11 linkn.1437A>G non_coding_transcript_exon_variant Exon 9 of 20 1

Frequencies

GnomAD3 genomes
AF:
0.573
AC:
86938
AN:
151788
Hom.:
28284
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.812
Gnomad AMR
AF:
0.504
Gnomad ASJ
AF:
0.661
Gnomad EAS
AF:
0.433
Gnomad SAS
AF:
0.505
Gnomad FIN
AF:
0.754
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.751
Gnomad OTH
AF:
0.597
GnomAD2 exomes
AF:
0.612
AC:
152378
AN:
249038
AF XY:
0.624
show subpopulations
Gnomad AFR exome
AF:
0.270
Gnomad AMR exome
AF:
0.382
Gnomad ASJ exome
AF:
0.665
Gnomad EAS exome
AF:
0.444
Gnomad FIN exome
AF:
0.756
Gnomad NFE exome
AF:
0.750
Gnomad OTH exome
AF:
0.654
GnomAD4 exome
AF:
0.705
AC:
1029903
AN:
1460584
Hom.:
374452
Cov.:
38
AF XY:
0.701
AC XY:
509502
AN XY:
726672
show subpopulations
African (AFR)
AF:
0.260
AC:
8703
AN:
33452
American (AMR)
AF:
0.394
AC:
17630
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.665
AC:
17384
AN:
26126
East Asian (EAS)
AF:
0.432
AC:
17160
AN:
39688
South Asian (SAS)
AF:
0.510
AC:
44012
AN:
86214
European-Finnish (FIN)
AF:
0.759
AC:
40400
AN:
53254
Middle Eastern (MID)
AF:
0.664
AC:
3824
AN:
5762
European-Non Finnish (NFE)
AF:
0.757
AC:
840525
AN:
1111044
Other (OTH)
AF:
0.667
AC:
40265
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
13597
27194
40791
54388
67985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19988
39976
59964
79952
99940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.573
AC:
86970
AN:
151906
Hom.:
28289
Cov.:
32
AF XY:
0.568
AC XY:
42182
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.271
AC:
11233
AN:
41472
American (AMR)
AF:
0.503
AC:
7684
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.661
AC:
2293
AN:
3470
East Asian (EAS)
AF:
0.432
AC:
2225
AN:
5150
South Asian (SAS)
AF:
0.506
AC:
2435
AN:
4808
European-Finnish (FIN)
AF:
0.754
AC:
7974
AN:
10570
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.751
AC:
50939
AN:
67856
Other (OTH)
AF:
0.599
AC:
1260
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1567
3134
4702
6269
7836
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.649
Hom.:
51152
Bravo
AF:
0.542
ExAC
AF:
0.614
AC:
74225
Asia WGS
AF:
0.448
AC:
1556
AN:
3476
EpiCase
AF:
0.737
EpiControl
AF:
0.742

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 20, 2022
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia 5 Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.39
T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.97
D
MetaRNN
Benign
0.0000034
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
6.3
PrimateAI
Uncertain
0.57
T
PROVEAN
Pathogenic
-5.2
D
REVEL
Benign
0.24
Sift
Uncertain
0.0030
D
Vest4
0.27
ClinPred
0.018
T
GERP RS
5.6
Varity_R
0.34
gMVP
0.23
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2502726; hg19: chr16-70972595; COSMIC: COSV59249510; COSMIC: COSV59249510; API